We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.6B
AUM Growth
+$1.35B
(+9.5%)
Cap. Flow
+$272M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
17.46%
Holding
2,121
New
637
Increased
418
Reduced
436
Closed
588
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$208M |
| 2 |
Charles River Laboratories
CRL
|
+$150M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$91.1M |
| 4 |
Keurig Dr Pepper
KDP
|
+$83.8M |
| 5 |
Medtronic
MDT
|
+$83.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$170M |
| 2 |
Boston Scientific
BSX
|
+$145M |
| 3 |
Procter & Gamble
PG
|
+$139M |
| 4 |
EPAM Systems
EPAM
|
+$101M |
| 5 |
Fidelity National Information Services
FIS
|
+$76.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.06% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Financials | 10.11% |
| 4 | Technology | 9.6% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Artivion
AORT
$1.27B
| $2.88M | 0.02% |
+155,981
| New | +$2.98M |
|
702
West Pharmaceutical
WST
$23.3B
| $2.87M | 0.02% |
10,445
-1,767
| -14% | -$468K |
|
703
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $2.87M | 0.02% |
49,098
-44,266
| -47% | -$2.5M |
|
|
QVCGA
704
DELISTED
QVC Group Inc Series A
QVCGA
| $2.86M | 0.02% |
+7,970
| New | +$3.77M |
|
705
ArcelorMittal
MT
$50.9B
| $2.86M | 0.02% |
+215,731
| New | +$2.6M |
|
706
Unifirst Corp
UNF
$5.38B
| $2.86M | 0.02% |
15,081
+6,212
| +70% | +$1.16M |
|
707
Helios Technologies
HLIO
$2.59B
| $2.81M | 0.02% |
77,143
+34,906
| +83% | +$1.35M |
|
708
HUB Group
HUBG
$2.93B
| $2.76M | 0.02% |
109,794
-25,710
| -19% | -$665K |
|
709
Cavco Industries
CVCO
$4.46B
| $2.74M | 0.02% |
+15,178
| New | +$2.9M |
|
710
Mueller Water Products
MWA
$3.94B
| $2.74M | 0.02% |
263,351
+111,516
| +73% | +$1.16M |
|
711
HEICO Corp Class A
HEI.A
$36.3B
| $2.72M | 0.02% |
+30,714
| New | +$2.59M |
|
712
General Mills
GIS
$19.5B
| $2.71M | 0.02% |
+43,964
| New | +$2.75M |
|
713
Snap-on
SNA
$21.1B
| $2.71M | 0.02% |
+18,415
| New | +$2.67M |
|
714
Liberty Latin America Class A
LILA
$1.57B
| $2.71M | 0.02% |
482,603
-144,556
| -23% | -$880K |
|
715
Applied Industrial Technologies
AIT
$12.9B
| $2.7M | 0.02% |
+49,012
| New | +$2.99M |
|
716
Booz Allen Hamilton
BAH
$8.59B
| $2.7M | 0.02% |
+32,536
| New | +$2.66M |
|
|
TREB.U
717
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
| $2.7M | 0.02% |
250,000
| – | – |
|
718
Ionis Pharmaceuticals
IONS
$9.25B
| $2.7M | 0.02% |
+56,862
| New | +$3.16M |
|
719
Air Products & Chemicals
APD
$65.2B
| $2.69M | 0.02% |
9,039
+490
| +6% | +$141K |
|
|
CMBT
720
CMB.TECH NV
CMBT
$4.46B
| $2.68M | 0.02% |
303,073
-704,903
| -70% | -$6.57M |
|
721
FMC
FMC
$1.39B
| $2.68M | 0.02% |
+25,294
| New | +$2.71M |
|
722
Matthews International
MATW
$878M
| $2.67M | 0.02% |
119,409
+88,018
| +280% | +$1.89M |
|
723
Five Below
FIVE
$11.5B
| $2.66M | 0.02% |
+20,981
| New | +$2.39M |
|
724
Vanda Pharmaceuticals
VNDA
$314M
| $2.65M | 0.02% |
274,854
+174,061
| +173% | +$1.86M |
|
725
Freeport-McMoran
FCX
$90.2B
| $2.65M | 0.02% |
+169,125
| New | +$2.44M |
|
Similar funds
Marshall Wace's Q3 2020 Portfolio in Review
As of Q3 2020, Marshall Wace held 2,121 positions worth $15.6B, up 9.5% from $14.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q3 2020 filing shows 637 new, 418 increased, 436 reduced and 588 closed positions. Its largest new stake was Keurig Dr Pepper: 2,859,399 shares worth $78.9M. The largest sale was Alibaba, an estimated $170M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q3 2020 buy was Keurig Dr Pepper: 2,859,399 shares worth $78.9M.
- Marshall Wace added most to Alphabet (Google) Class A in Q3 2020, an estimated $208M increase.
- Marshall Wace's biggest Q3 2020 reduction was Alibaba, cutting an estimated $170M.
- Marshall Wace fully exited Procter & Gamble in Q3 2020, selling an estimated $139M.
- Marshall Wace's ten largest holdings make up 17% of its $15.6B portfolio in Q3 2020.
- Marshall Wace opened 637 new positions and closed 588 in Q3 2020.
- Marshall Wace's portfolio value rose 9.5% quarter-over-quarter to $15.6B.
Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.